(Q37919520)

English

Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network

scientific article published on 18 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network (English)

1 reference

Europe PubMed Central

25 August 2017

mantle cell lymphoma

1 reference

based on heuristic

inferred from title

Olivier Hermine

20

1 reference

Europe PubMed Central

25 August 2017

3

object named as

Sílvia Beà

1 reference

Europe PubMed Central

25 August 2017

object named as

Eva Hoster

21

0 references

Itziar Salaverria

object named as

Itziar Salaverria

5

0 references

object named as

Jan Walewski

17

0 references

object named as

Umberto Vitolo

15

0 references

Hanneke C Kluin-Nelemans

object named as

Hanneke C Kluin-Nelemans

2

0 references

8

object named as

Gael Roue

1 reference

Europe PubMed Central

25 August 2017

Martin Dreyling

1

object named as

Martin Dreyling

1 reference

Europe PubMed Central

25 August 2017

Michael Unterhalt

19

object named as

Michael Unterhalt

1 reference

Europe PubMed Central

25 August 2017

author name string

Elena Hartmann

4

1 reference

Europe PubMed Central

25 August 2017

Grit Hutter

6

1 reference

Europe PubMed Central

25 August 2017

Patricia Perez-Galan

7

1 reference

Europe PubMed Central

25 August 2017

Christiane Pott

9

1 reference

Europe PubMed Central

25 August 2017

Steven Le Gouill

10

1 reference

Europe PubMed Central

25 August 2017

Sergio Cortelazzo

11

1 reference

Europe PubMed Central

25 August 2017

Simon Rule

12

1 reference

Europe PubMed Central

25 August 2017

Georg Hess

13

1 reference

Europe PubMed Central

25 August 2017

Francesco Zaja

14

1 reference

Europe PubMed Central

25 August 2017

Michal Szymczyk

16

1 reference

Europe PubMed Central

25 August 2017

Vincent Ribrag

18

1 reference

Europe PubMed Central

25 August 2017

European Mantle Cell Lymphoma Network

22

1 reference

Europe PubMed Central

25 August 2017

publication date

18 August 2011

1 reference

Europe PubMed Central

25 August 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

25 August 2017

52

1 reference

Europe PubMed Central

25 August 2017

12

1 reference

Europe PubMed Central

25 August 2017

2226-2236

1 reference

Europe PubMed Central

25 August 2017

Current treatment standards and emerging strategies in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Outcome of deferred initial therapy in mantle-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.600488

21 January 2018

Identifiers

10.3109/10428194.2011.600488

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37919520&oldid=2092777216"